Longeveron LLC
Price & Volume
Stats
See moreOpen | $6.87 |
Previous Close | $6.80 |
Day Range | $6.87-$6.87 |
52W Range | $4.75-$12.30 |
Market Cap | $2.2M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $1.1M |
Revenue Growth (YoY) | -9.2% |
Gross Profit (12 Mos) | $828,000 |
Diluted EPS | -$10.24 |
News
See moreYahoo Finance • 4 days ago
Longeveron Announces 1-for-10 Reverse Stock Split
Yahoo Finance • 16 days ago
Longeveron expects ELPIS II HLHS data in mid-september while cash runway extends into Q4 2026
Yahoo Finance • 2 months ago
Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease
Yahoo Finance • 2 months ago
Pre-Market Movers: BYAH, LXEO, ELTX Swing Big
About
CEO | Mr. Stephen H. Willard Esq. |
Address | Life Science & Technology Park, Miami, FL, United States, 33136 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 38 |